Osteoclast recruiting activity in bone matrix
- PMID: 8086857
- DOI: 10.1016/s0169-6009(08)80238-3
Osteoclast recruiting activity in bone matrix
Abstract
An activity that recruits osteoclasts has been identified and partially characterized from bone matrix. Bone-derived osteoclast recruiting activity (BORA) was co-purified with osteogenin, a bone inductive protein. Osteogenin was extracted from bovine bone with 6 M urea and purified by chromatography on hydroxyapatite, heparin-Sepharose and Sephacryl S-200 gel filtration. The biologically active osteoclast formation-stimulating material was further purified by C18 reverse phase HPLC. BORA is obviously distinct from osteogenin and transforming growth factor beta (TGF-beta), since further purified osteogenin and pure TGF-beta did not stimulate the formation of osteoclast-like cells. BORA (0.1-10 micrograms/ml) stimulated the formation of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells (MNC) in a dose-dependent manner. These multinucleated cells resorbed bone when cultured on bovine bone slices. The effect of BORA is primarily directed to differentiate osteoclast precursors, since it did not stimulate osteoclast function in in vitro resorption assay where disaggregated rat osteoclasts were cultured on bovine bone slices. However, after 24 h preincubation with 50 nM PTH in the mouse calvaria assay, BORA at 10 micrograms/ml significantly stimulated bone resorption.
Similar articles
-
The purification and partial characterization of bone resorptive polypeptides from bovine bone matrix.Biochim Biophys Acta. 1994 Nov 11;1201(2):193-202. doi: 10.1016/0304-4165(94)90041-8. Biochim Biophys Acta. 1994. PMID: 7947932
-
Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.J Bone Miner Metab. 2004;22(5):415-29. doi: 10.1007/s00774-004-0503-5. J Bone Miner Metab. 2004. PMID: 15316862
-
Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.Endocrinology. 1995 Jan;136(1):124-31. doi: 10.1210/endo.136.1.7828521. Endocrinology. 1995. PMID: 7828521
-
Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates.Plast Reconstr Surg. 1992 Sep;90(3):382-93. doi: 10.1097/00006534-199209000-00004. Plast Reconstr Surg. 1992. PMID: 1325064
-
Inhibitory effects of the bone-derived growth factors osteoinductive factor and transforming growth factor-beta on isolated osteoclasts.Endocrinology. 1990 Jun;126(6):3069-75. doi: 10.1210/endo-126-6-3069. Endocrinology. 1990. PMID: 1693566
Cited by
-
Metrical and histological investigation of the effects of low-level laser therapy on orthodontic tooth movement.Lasers Med Sci. 2012 Jan;27(1):131-40. doi: 10.1007/s10103-010-0853-2. Epub 2010 Oct 31. Lasers Med Sci. 2012. PMID: 21038101
-
Ameliorating orthodontic relapse using laser bio-stimulation and mesenchymal stem cells in rats.J Genet Eng Biotechnol. 2024 Mar;22(1):100331. doi: 10.1016/j.jgeb.2023.100331. Epub 2024 Jan 22. J Genet Eng Biotechnol. 2024. PMID: 38494247 Free PMC article.
-
Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence.Osteoporos Int. 2007 Dec;18(12):1565-81. doi: 10.1007/s00198-007-0441-x. Epub 2007 Aug 12. Osteoporos Int. 2007. PMID: 17694399 Review.
-
Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12.Histochem Cell Biol. 2003 Nov;120(5):391-400. doi: 10.1007/s00418-003-0587-3. Epub 2003 Nov 5. Histochem Cell Biol. 2003. PMID: 14600836
-
The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.Int Orthop. 2014 Mar;38(3):635-47. doi: 10.1007/s00264-013-2201-1. Epub 2013 Dec 19. Int Orthop. 2014. PMID: 24352822 Free PMC article. Review.